The risk of developing rare blood clots is even lower when receiving a second dose of the AstraZeneca COVID-19 vaccine, with experts reiterating that the benefits outweigh the risk in Canada’s race to get inoculated.
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe